Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The BRCT Domain from the Homologue of the Oncogene PES1 in Leishmania major (LmjPES) Promotes Malignancy and Drug Resistance in Mammalian Cells. | Int J Mol Sci | 2022 | 36361992 | PubTator, text mining | PubMed |
| Artificial Intelligence Predicted Overall Survival and Classified Mature B-Cell Neoplasms Based on Immuno-Oncology and Immune Checkpoint Panels. | Cancers (Basel) | 2022 | 36358737 | PubTator, text mining | PubMed |
| Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors. | NPJ Breast Cancer | 2022 | 36351947 | PubTator, text mining | PubMed |
| Cellular plasticity and immune microenvironment of malignant pleural effusion are associated with EGFR-TKI resistance in non-small-cell lung carcinoma. | iScience | 2022 | 36339256 | PubTator, text mining | PubMed |
| A systematic and thematic analysis of the top 100 cited articles on mRNA vaccine indexed in Scopus database. | Hum Vaccin Immunother | 2022 | 36328513 | PubTator, text mining | PubMed |
| Immunotherapy approaches for hematological cancers. | iScience | 2022 | 36325064 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future. | Front Pharmacol | 2022 | 36324681 | PubTator, text mining | PubMed |
| Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses. | Front Immunol | 2022 | 36311790 | PubTator, text mining | PubMed |
| The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors. | Nat Commun | 2022 | 36309516 | PubTator, text mining | PubMed |
| Clinical cancer immunotherapy: Current progress and prospects. | Front Immunol | 2022 | 36304470 | PubTator, text mining | PubMed |
| Recent Advances in DNA Vaccines against Lung Cancer: A Mini Review. | Vaccines (Basel) | 2022 | 36298450 | PubTator, text mining | PubMed |
| Topically Applied Resiquimod versus Imiquimod as a Potential Adjuvant in Melanoma Treatment. | Pharmaceutics | 2022 | 36297510 | PubTator, text mining | PubMed |
| Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy. | Pathogens | 2022 | 36297203 | PubTator, text mining | PubMed |
| Alterations in Gene Pair Correlations as Potential Diagnostic Markers for Colon Cancer. | Int J Mol Sci | 2022 | 36293321 | PubTator, text mining | PubMed |
| Modification of Regulatory T Cell Epitopes Promotes Effector T Cell Responses to Aspartyl/Asparaginyl β-Hydroxylase. | Int J Mol Sci | 2022 | 36293298 | PubTator, text mining | PubMed |
| The Detection of Immunity against WT1 and SMAD4P130L of EpCAM+ Cancer Cells in Malignant Pleural Effusion. | Int J Mol Sci | 2022 | 36293034 | PubTator, text mining | PubMed |
| Virtual Screening and Quantitative Structure-Activity Relationship of Moringa oleifera with Melanoma Antigen A (MAGE-A) Genes against the Therapeutics of Non-Small Cell Lung Cancers (NSCLCs). | Cancers (Basel) | 2022 | 36291836 | PubTator, text mining | PubMed |
| mRNA-Based Approaches to Treating Liver Diseases. | Cells | 2022 | 36291194 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitors and Other Immune Therapies in Breast Cancer: A New Paradigm for Prolonged Adjuvant Immunotherapy. | Biomedicines | 2022 | 36289773 | PubTator, text mining | PubMed |
| Conformationally Restricted Dipeptide-Based Nanoparticles for Delivery of siRNA in Experimental Liver Cirrhosis. | ACS Omega | 2022 | 36278038 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=21